Advisory Cmte. Conflict of Interest Waivers Common; Avandia Is High Water Mark
Executive Summary
As currently convened, the majority of FDA advisory committee meetings on drugs would likely violate a limit on participation by experts with a financial conflict of interest being considered by Congress
You may also be interested in...
FDA Casts Wide Net For Advice on Avandia
Agency increases number of voting members for the meeting of the Endocrinologic and Metabolic and Drug Safety and Risk Management Advisory Committees to 33, up 10 from 2007. Half of the committee's voting members also participated in the first review of rosiglitazone's postmarketing safety.
Advisory Committee Conflict Of Interest Waivers Get Support From Study
FDA's policy of granting waivers for financial conflicts of interest for advisory committee members is getting support from an independent review. According to an analysis commissioned by the agency, constructing advisory committees free from conflicts of interest would be expensive and time-consuming and may be unfeasible for certain topics and fields of expertise
Advisory Committee Conflict Of Interest Waivers Get Support From Study
FDA's policy of granting waivers for financial conflicts of interest for advisory committee members is getting support from an independent review. According to an analysis commissioned by the agency, constructing advisory committees free from conflicts of interest would be expensive and time-consuming and may be unfeasible for certain topics and fields of expertise